Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma.
10.3350/kjhep.2009.15.2.227
- Author:
Jeong HEO
1
Author Information
1. Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. jheo@pusan.ac.kr
- Publication Type:Review
- Keywords:
Carcinoma, Hepatocellular;
Tyrosine kinase inhibitor;
Sorafenib
- MeSH:
Adenosine Triphosphatases/*genetics;
Amino Acid Substitution;
Cation Transport Proteins/*genetics;
Genotype;
Haplotypes;
Hepatolenticular Degeneration/diagnosis/*genetics;
Humans;
Mutation;
Republic of Korea
- From:The Korean Journal of Hepatology
2009;15(2):227-230
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
No abstract available.
